Multiple Site Hydrogen Isotope Labelling of Pharmaceuticals
- 28 July 2020
- journal article
- research article
- Published by Wiley in Angewandte Chemie
- Vol. 132 (47) , 21300-21306
Abstract
Radiolabelling is fundamental in drug discovery and development as it is mandatory for preclinical ADME studies and late‐stage human clinical trials. Herein, a general, effective, and easy to implement method for the multiple site incorporation of deuterium and tritium atoms using the commercially available and air‐stable iridium precatalyst [Ir(COD)(OMe)]2 is described. A large scope of pharmaceutically relevant substructures can be labelled using this method including pyridine, pyrazine, indole, carbazole, aniline, oxa‐/thia‐zoles, thiophene, but also electron‐rich phenyl groups. The high functional group tolerance of the reaction is highlighted by the labelling of a wide range of complex pharmaceuticals, containing notably halogen or sulfur atoms and nitrile groups. The multiple site hydrogen isotope incorporation has been explained by the in situ formation of complementary catalytically active species: monometallic iridium complexes and iridium nanoparticles.Keywords
Funding Information
- H2020 European Research Council (675071)
This publication has 36 references indexed in Scilit:
- C−H Functionalisation for Hydrogen Isotope ExchangeAngewandte Chemie International Edition, 2018
- Methoden der C‐H‐Funktionalisierung für den WasserstoffisotopenaustauschAngewandte Chemie, 2018
- Deuterium‐ und tritiummarkierte Verbindungen: Anwendungen in den modernen BiowissenschaftenAngewandte Chemie, 2018
- Deuterium‐ and Tritium‐Labelled Compounds: Applications in the Life SciencesAngewandte Chemie International Edition, 2018
- Tactics for preclinical validation of receptor-binding radiotracersNuclear Medicine and Biology, 2017
- Isotope chemistry; a useful tool in the drug discovery arsenalBioorganic & Medicinal Chemistry Letters, 2015
- Tritium: a coming of age for drug discovery and development ADME studiesJournal of Labelled Compounds and Radiopharmaceuticals, 2012
- Ligand binding assays at equilibrium: validation and interpretationBritish Journal of Pharmacology, 2010
- Practical Aspects of Radioligand BindingCurrent Protocols in Pharmacology, 2006
- Synthetic Tritium Labeling: Reagents and MethodologiesSynthesis, 2002